The South African Health Products Regulatory Authority recommends that the rollout of Johnson & Johnson COVID-19 vaccines be resumed, subject to specific conditions. The regulator wants stricter screening and monitoring of recipients who are at risk of a blood clotting disorder. Participant information sheets and informed consent forms must also be updated to include the newly identified adverse events. Mark Roughton reports.
IN: “Health Minister Zweli Mkhize…”
OUT: SOC
DUR: 0:32
http://www.fsnradionews.com/feeds/0421SA-resumes-rollout.mp3